In a recent article for Drug Target Review, Taconic's Dr. Paul Volden emphasizes how humanized immune system (HIS) mouse... Read More
Getting Precise: How Humanized Models Aid in Biologics Drug Discovery
Apr 02, 2020
In a recent article for Drug Target Review, Taconic's Dr. Paul Volden emphasizes how humanized immune system (HIS) mouse... Read More
The concept of T cell exhaustion and the associated immune response has become a priority for immuno-oncology researchers. Taconic's... Read More
Genetic Engineering & Biotechnology News recently published an article discussing the progression of advanced animal models for drug development... Read More
The IP landscape surrounding the use of the CRISPR/Cas9 technology (and variants of it) can pose challenges for model... Read More
An article recently published in DDN highlights Taconic Biosciences's new diet-induced NASH mouse model and its importance for preclinical... Read More
Two of Taconic Biosciences's newest products are highlighted in a recent article published in Outsourcing-Pharma. The first, TruBIOME®, is... Read More
On July 29, 2019, Taconic Biosciences announced the launch of the first commercially-available diet-induced NASH rodent model. These models... Read More
In a recent article published in International Biopharmaceutical Industry, Taconic Biosciences' Dr. Alexander Maue highlights the importance of the... Read More
On July 27, 2019, 40 female C57BL6/NTac mice were sent to space on SpaceX's 18th commercial resupply to the... Read More
In a recent article published in the Journal of Precision Medicine, Taconic Biosciences' scientists Dr. Philip Dubé, Dr. Ivan... Read More
Welcome! Tell us a little about yourself